ASCO 2026: 92% Tumor Shrinkage and 100% Disease Control in Metastatic Pancreatic Cancer with Vopimetostat + Daraxonrasib
Friends, there are numbers that make you stop and take a deep breath before you see or read them. Take a moment and think about
Gedatolisib + Palbociclib + Fulvestrant Doubled Progression-Free Survival in Metastatic Breast Cancer – VIKTORIA-1 Results at ASCO 2026
New Update: Gedatolisib in the VIKTORIA-1 Study Presented at ASCO 2026 Viktoria is not a patient, and she is not a woman I know… 😊 This
Amivantamab (Rybrevant FASPRO) – Major Breakthrough in Recurrent/Metastatic Head and Neck Cancer: Pivotal ASCO 2026 Results
A Major Breakthrough in Metastatic Head and Neck Cancer: Amivantamab (Rybrevant FASPRO) Shows Pivotal Results at ASCO 2026 Yesterday (May 31, 2026), mature and highly
Expanded Access Program – Daraxonrasib | Guidelines for Patients and Families
Important update for our previously treated metastatic pancreatic cancer (PDAC) patients: Date 4.5.2026 Time 15:15, written by Nir Erez Revolution Medicines received FDA authorization to
The Objective Truth: Why in Advanced Cancer, AI “Information” Is Only 10% of the Solution
Even if you know how to use AI tools professionally, in the end, you need a drug in your vein, not a list of results
How to find innovative treatments for metastatic cancer? A short guide for stage 4 patients
How to find innovative treatments for metastatic cancer? A short guide for stage 4 patients Patients with metastatic cancer often encounter situations where it seems
What’s New in Breast Cancer? ESMO 2025 Updates
🎗 October was Breast Cancer Awareness Month and now it’s behind us. Now, I want to talk to you about what really matters: reality. My
Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer
Meet Zongertinib (Hernexeos) – a breakthrough drug for patients with HER2‑mutant lung cancer Zongertinib (brand name: Hernexeos) is an innovative oral medication that acts as
Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy
Breakthrough Medical Vaccine for Glioblastoma (GBM): Personalized Life-Extending Immunotherapy A new international study introduces an innovative therapeutic option for glioblastoma (GBM) patients: a personalized vaccine
🧠 New treatment for leptomeningeal metastases – hope for advanced-stage cancer patients
🧠 A new treatment for leptomeningeal metastases offers real hope for advanced-stage cancer patients. A groundbreaking study published in Nature Medicine and presented at ASCO
New Treatment for Metastatic Triple Negative Breast Cancer – ASCO 2025
Metastatic Triple-Negative Breast Cancer: ASCO 2025 Highlights Breakthrough Therapy Metastatic triple-negative breast cancer (TNBC) is one of the most aggressive and difficult-to-treat forms of breast
👨🍳 Tomasz Jakubiak Returns to Poland After Cancer Treatment in Israel
We’re happy to share some good news – the well-known and highly respected chef Tomasz Jakubiak has returned to Poland after an extended stay
